NCT07303400

Brief Summary

The objective of this project is to test the efficiency of a novel developed protocol for direct real-time metagenomic sequencing of Lower Respiratory Infection samples. The investigators aim to assess the anticipation time, compared to the traditional culturing methods and the accuracy, compared to gold standards

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 9, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

March 25, 2026

Status Verified

August 1, 2025

Enrollment Period

7 months

First QC Date

December 2, 2025

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • test positivity

    assess the effectiveness in detection of positive (Gram+ vs Gram- vs mixed culture samples) vs negative samples

    Baseline

  • species identification

    Assess the effectiveness in recognizing the correct bacterial species

    Baseline

Secondary Outcomes (1)

  • anticipation time

    Baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients tested for Lower Respiratory tract infections using bronchoalveolar lavage samples

You may qualify if:

  • Willingness and ability to provide written informed consent prior to performing the study procedures
  • Patients older than 18 years of age
  • Suspected bacterial Lower Respiratory Infection (LRI)
  • µL of lower respiratory tract sample (e.g. Bronchoalveolar lavage) are available after the routine diagnostic procedures are over

You may not qualify if:

  • Low amount of leftover specimen
  • Complex diagnosis: clinicians could require further analysis after the first diagnosis is produced
  • A sample of the same patient has been already included in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, Pavia, 27100, Italy

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

December 2, 2025

First Posted

December 24, 2025

Study Start

June 9, 2025

Primary Completion

December 31, 2025

Study Completion

May 1, 2026

Last Updated

March 25, 2026

Record last verified: 2025-08

Locations